Literature DB >> 31246750

Ectopic Opening of the Common Bile Duct into the Duodenal Bulb: Diagnosis and Therapeutic Management and Considerations for Timing of Surgery and Duration of Follow-up After Initial Endoscopic Retrograde Cholangiopancreatography.

Bahtiyar Muhammedoğlu1.   

Abstract

INTRODUCTION: Ectopic opening of the common bile duct (EO-CBD) is a rare pathology, and its management is important. To date, only a few studies have been conducted for EO-CBD due to its low incidence.
MATERIALS AND METHODS: A retrospective review was conducted on 54 patients with available prospective data. Among them, 30 patients (group 1) underwent choledochoduodenostomy for reasons other than anomalous opening, and 24 patients (group 2) had an EO-CBD.
RESULTS: Endoscopic retrograde cholangiopancreatography (ERCP) was performed for 24 patients with duodenal deformity and apical stenosis. EO-CBD was detected in 2.72% of all patients who underwent ERCP (24/880 ERCPs). The occurrence of hyperbilirubinemia (total bilirubin >1.2 mg/dL) was not significantly different between groups: 3.83±4.57 mg/dL for group 1 and 2.26±2.17 mg/dL for group 2.
CONCLUSIONS: Failed ERCP, giant stones, and recurrent episodes (>2) of cholangitis requiring ERCP constitute indications for surgical treatment in cases of EO-CBD into the duodenum.

Entities:  

Mesh:

Year:  2019        PMID: 31246750     DOI: 10.1097/SLE.0000000000000695

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  2 in total

1.  Duodenal stenosis associated with an ectopic opening of the common bile duct into the duodenal bulb: a case report.

Authors:  Kazuki Kobayashi; Michinori Murayama; Hidekazu Sugasawa; Makoto Nishikawa; Kiyoshi Nishiyama; Hiroaki Takeo
Journal:  Surg Case Rep       Date:  2021-12-16

2.  Ectopic opening of the common bile duct into the duodenal bulb with recurrent choledocholithiasis: A case report.

Authors:  Hao Xu; Xin Li; Ke-Xiang Zhu; Wen-Ce Zhou
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.